| 000 | 00856 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250512005555.0 | ||
| 264 | 0 | _c19890223 | |
| 008 | 198902s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(89)91238-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aClarke, C E | |
| 245 | 0 | 0 |
_aNeuroleptic malignant syndrome. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cJan 1989 |
||
| 300 |
_a221 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_aCreatine Kinase _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeuroleptic Malignant Syndrome _xblood |
| 700 | 1 | _aShand, D | |
| 700 | 1 | _aYuill, G M | |
| 700 | 1 | _aGreen, M H | |
| 773 | 0 |
_tLancet (London, England) _gvol. 1 _gno. 8631 _gp. 221 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(89)91238-5 _zAvailable from publisher's website |
| 999 |
_c2569076 _d2569076 |
||